Gemeprost

DB08964ApprovedWithdrawnSmall molecule

Gemeprost is a prostaglandin E1 analogue used for cervical dilation and, in combination with mifepristone, for pregnancy termination. Gemeprost is a prostaglandin E1 (PGE1) analog and antiprogestogen used for preoperative dilation of the cervix before surgical abortion.

Chemical structure of Gemeprost
Mechanism
Curator reviewed · 1 reference
Primary indication
Indicated for the softening and dilatation of the cervix uteri prior to transcervical, intrauterine operative procedures in the first trimester of pregnancy or facilitating therapeutic termination of pregnancy in patients in the second trimester of...Curator reviewed · 2 structured indications
Formula / weight
C23H38O5 · 394.552 g/mol (avg)
Code names
SC-37681

Resolves to

Clinical / RWD
Structure
InChIKeyKYBOHGVERHWSSV-VNIVIJDLSA-NSMILESCCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCC\C=C\C(=O)OC

What you can answer from here — as of August 01, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Drug interactionStructured to mechanism, not free text
Sign in
11Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
2Marketed productsAcross 2 countries and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 17 drug categories
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Gemeprost, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account